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212a Monday, February 22, 2010control ionic conditions in the cell and energise osmotic potentials, secondary
transport schemes and ionotropic signalling.
A surprising finding from the Naþ,Kþ-ATPase structure was the docking of
two conserved tyrosine residues at the C-terminus of the alpha subunit into
the transmembrane domain, hinting that this was a previously unidentified
regulatory element. Several mutations causing human neurological syndromes
have subsequently been mapped to the C-terminal structure element, also
clearly indicating that conservation of the structure is important for pump
function.
Mutational analysis confirmed this and prompted our further analysis by elec-
trophysiology and molecular dynamics simulations, which have shown a pro-
found effect of the C-terminus on the electrogenic transport properties. We
further propose that the C-terminal region forms a binding pocket that can be
exploited for pharmacological intervention in cardiovascular and neurological
disease.
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In the central nervous system, glutamate transporters are responsible for the
glutamate clearance following rounds of neurotransmission. They are molec-
ular pumps, which utilizes the energy of pre-existing electrochemical gradi-
ents of ions to drive substrate uptake against steep concentration gradients. So-
dium coupled aspartate transporter from Pyrococcus horikoshii, GltPh, is
a homologue of the mammalian transporters and has served as a model sys-
tem, within which to understand the molecular details of transport. The previ-
ously determined crystal structures of GltPh revealed the substrate and sodium
binding sites located near the extracellular solution leaving the question of
how they reach the cytoplasm unanswered. Recently, we have determined
the crystal structure of a double cysteine mutant of GltPh, captured by
cross-linking in a novel conformational state. In this state the substrate-bind-
ing sites are near the cytoplasmic surface of the protein. These findings sug-
gest a novel and unexpected mechanism, by which GltPh and, by analogy
mammalian glutamate transporters catalyze trans-membrane transport of their
substrates.
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Optical control of proteins provides critical advantages for studying cell signal-
ing and offers great promise in biotechnology and biomedical research.We have
developed a series of photochromic ligands (PCLs) that target voltage-gated ion
channels. They possess an azobenzene photoswitch connected on one side to a
quaternary ammonium ligand (internal blocker for potassium, sodium and cal-
cium channels) and on the other side to a variety of chemical groups. The azo-
benzene photoisomerizes between cis and trans configurations using different
wavelengths of light, thereby repetitively turning on and off ion flow.
Alteration of the R group makes our approach very modular. First, increasing
hydrophobicity allows better membrane penetration and therefore greater
potency of the PCL. Second, PCLs with a charged R group require hydrophilic
pathways to cross cell membranes and can be specifically targeted to cells ex-
pressing entry-route proteins. Third, selectivity for certain ion channels can be
attained, allowing amore precise con-
trol over cellular excitability. Fourth,
some PCLs act as cis blockers, offer-
ing the advantage of being silent in
the dark. Finally, modifying the R
group can be used to tune the spectral
characteristics of the PCL, with po-
tential interest for vision restoration.1106-Plat
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A-kinase-anchoring protein (AKAP)79/150 mediated PKC phosphorylation of
M-type (KCNQ) channels is involved in M current (IM) suppression by musca-
rinicM1, but not bradykininB2 receptors (Hoshi et al.Nat. Cell Biol. 7:1066-73).
In this study, we first explored the involvement of AKAP79/150 in muscarinic
suppression of KCNQ currents by co-transfecting AKAP79 with KCNQ1-5
subunits in CHO cells stably expressing M1 receptors. Expression of AKAP79
sensitized KCNQ2-5 and KCNQ2/3, but not KCNQ1, channels to suppression
by the M1 receptor agonist oxotremorine (oxo-M). Mutation of the PKC phos-
phorylation site onKCNQ4 (T553A) eliminated the effect of AKAP79, confirm-
ing the role of PKC. Co-transfection of wild-type, but not dominant negative,
calmodulin abolished the effect of AKAP79 on KCNQ2/3 channels. We asked
if purinergic and angiotensin suppression of IM in superior cervical ganglion
(SCG) sympathetic neurons involvesAKAP79/150, since purinergic P2Y recep-
tors depress IM in SCG neurons via a similar mechanism to that of bradykinin,
involving IP3-mediated Ca
2þ signals, whereas angiotensin AT1 receptors de-
press IM via a similar mechanism as M1 receptors, by depletion of PIP2. Trans-
fection of DA-AKAP79, which lacks the A-domain necessary for PKC binding,
did not affect IM suppression by the purinergic agonist UTP (2 mM), nor by
bradykinin (100 nM), but did reduce IM suppression by oxo-M (1mM) and angio-
tensin II (500 nM).We also tested association ofAKAP79withM1,B2, P2Y6 and
AT1 receptors via FRET experiments on CHO cells under TIRF microscopy,
which revealed weaker FRET between AKAP79 and P2Y6 or B2 receptors
than for M1 and AT1 receptors. Our data suggest AKAP79/150 action general-
izes to KCNQ2-5 subtypes, is disrupted by calmodulin, and is involved in angio-
tensin, but not in purinergic, suppression of neuronal M current. Supported by
NIH grants R01 NS043394 and R01 NS065138.
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Peptide toxins found in a wide array of venoms block Kþ channels causing
profound physiological and pathological effects. Here, we describe the first
functional Kþ channel-blocking toxin domain in a mammalian protein. Matrix
metalloprotease 23 (MMP23) contains a domain (MMP23TxD) that is evolu-
tionarily related to peptide toxins from sea anemones. MMP23TxD shows close
structural similarity to the sea anemone toxins BgK and ShK, and the domain
blocks Kþ channels in the nanomolar to low micromolar range (Kv1.6 >
Kv1.3>Kv1.1¼Kv3.2>Kv1.4 in decreasing order of potency), while sparing
other Kþ channels (Kv1.2, Kv1.5, Kv1.7, KCa3.1). Full-length MMP23 sup-
presses Kþ channels with a pattern of inhibition consistent with MMP23TxD
activity. Our results provide clues to the structure and function of the vast family
of proteins that contain domains related to sea anemone toxins. Evolutionary
pressure to maintain a channel-modulatory function may contribute to the con-
servation of this domain throughout the plant and animal kingdom.
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Phagocytes play an essential role in host defence against pathogens by gener-
ating reactive oxygen species (ROS). Effector T helper (Th) cells migrating to
sites of infection will be exposed to this highly oxidative environment. Here we
show how Th-cells respond and adapt to ROS. Oxidation affects different
Ca2þ-signalling pathways essential for T-cell function. ORAI1 channels are
inhibited with an IC50 of ~40 mM H2O2, but ORAI3 channels are insensitive.
We identify cysteine (C195) of ORAI1, absent in ORAI3, as the major redox
